Novartis is chopping 400 jobs in India after striking new distribution pact
Novartis has been focused on growing its operations in India, with new research and manufacturing additions. Now, it’s in the process of cutting ties with around 400 staffers in the subcontinent after striking a new sales and distribution deal for some of its established medicines.
The pharma giant put out word on Friday that it has forged a new deal with Dr. Reddy’s covering the “Voveran range, the Calcium range and Methergine.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.